MSR40 Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1576
https://www.valueinhealthjournal.com/article/S1098-3015(23)01676-5/fulltext
Section Title :
Section Order :
10973
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01676-5&doi=10.1016/j.jval.2023.03.1576